Cargando…
Current status of pulmonary arterial hypertension in Korea
Pulmonary arterial hypertension (PAH) is characterized by remodeling of the distal pulmonary arteries resulting in high pulmonary vascular resistance and, eventually, right ventricular heart failure. Although current advances in PAH therapy have improved outcomes, poor survival remains a reality wor...
Autores principales: | Jang, Albert Youngwoo, Chung, Wook-Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association of Internal Medicine
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6610200/ https://www.ncbi.nlm.nih.gov/pubmed/31272141 http://dx.doi.org/10.3904/kjim.2019.185 |
Ejemplares similares
-
Pulmonary Hypertension in Heart Failure
por: Jang, Albert Youngwoo, et al.
Publicado: (2021) -
Pulmonary arterial hypertension due to antiphospholipid syndrome initially mimicking chronic thromboembolic pulmonary hypertension
por: Yeo, Jina, et al.
Publicado: (2022) -
15 years journey of idiopathic pulmonary arterial hypertension with BMPR2 mutation
por: Ahn, Kyung Jin, et al.
Publicado: (2019) -
Stem Cell and Exosome Therapy in Pulmonary Hypertension
por: Oh, Seyeon, et al.
Publicado: (2022) -
Echocardiographic Screening Methods for Pulmonary Hypertension: A Practical Review
por: Jang, Albert Youngwoo, et al.
Publicado: (2020)